Hepatitis C News and Research

Latest Hepatitis C News and Research

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

In the 1970’s and 80’s thousands of people were infected with hepatitis C and HIV due to transfusion of contaminated blood that contained these viruses. A spokesperson for Theresa May, James Slack, today said that she, her health secretary Jeremy Hunt and the MPs sat together to announce a full review and inquiry into this disaster.

12 Jul 2017

Cancer death rates in rural America slower to decline compared to urban areas

According to the CDC, the cancer death rates nationwide have been on the decline. The reduction in these rates however is much slower in the rural areas than in other regions.

6 Jul 2017

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

A new report finds more than half of all cancer deaths in men in 2013 in China and more than a third of those in women were attributable to a group of potentially modifiable risk factors: smoking, alcohol, nutrition, weight, physical activity, and infections.

6 Jul 2017

Preserved placenta is associated with risk of infection

A recent case study published by Centers for Disease Control and Prevention highlighted that capsules of dehydrated placenta prepared for human consumption can be a source of infectious agents.

30 Jun 2017

Health care battle on hill has veterans defending Obamacare benefits

Air Force veteran Billy Ramos, from Simi Valley, Calif., is 53 and gets health insurance for himself and for his family from Medicaid — the government insurance program for low-income people.

30 Jun 2017

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Many individuals with the blood disorder thalassaemia also carry the hepatitis C virus (HCV) due to contaminated transfusions before 1990.

29 Jun 2017

Vaccines can be blamed for any illness even with lack of evidence says EU court

In a landmark judgment yesterday, the Court of Justice of the European Union ruled that courts could consider vaccines to be the reason for an illness despite the absence of any concrete evidence to support the connection.

21 Jun 2017

A ‘safe’ space to shoot up: Worth a try in California?

Tawny Biggs' seemingly happy childhood in the northern Los Angeles County suburb of Santa Clarita, Calif., showed no outward sign that she would one day struggle with drug addiction.

19 Jun 2017

Exclusive: White House task force echoes pharma proposals

President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration's efforts to lower drug prices are shrouded in secrecy.

16 Jun 2017

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Republicans in both the House and the Senate are considering big cuts to Medicaid. But those cuts endanger addiction treatment, which many people receive through the government health insurance program.

14 Jun 2017

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Pfizer Inc., in partnership with Parents magazine, announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease, and the measures parents can take to help prevent them.

14 Jun 2017

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

The US Food and Drug Administration this Thursday (8th June 2017) directed pharmaceutical company Endo Pharmaceuticals to remove one of its powerful opioid painkillers Opana ER, that provides a long term relief of pain but also poses a risk of drug abuse.

9 Jun 2017

UNC researchers identify how class of antiviral drugs interacts with HCV

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.

9 Jun 2017

Heroin use in the U.S. estimated to cost society more than $51 billion

Heroin use in the United States was estimated to cost society more than $51 billion in 2015, according to new research at the University of Illinois at Chicago.

9 Jun 2017

Drinking few cups of coffee or tea may protect against liver fibrosis, study finds

Chronic liver diseases rank as the 12th cause of death worldwide and many of these disorders are associated with unhealthy lifestyles. Conversely, a healthier lifestyle can help prevent or reverse liver disease.

6 Jun 2017

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

The survey results suggest a wide variation in existing national testing policy and practice when it comes to hepatitis B and C - with overall limited monitoring of testing, diagnosis, and treatment across EU/EEA Member States.

1 Jun 2017

Grifols provides Procleix Zika Virus Assay to screen blood donations in countries that accept products with CE marking

Grifols, one of the world’s leading producers of plasma-derived medicines, now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood. CE marking means a product conforms to relevant legislation for sale in the European economic area.

29 May 2017

New drug offers hope to patients with hepatitis C

Patients with hepatitis C who suffer from advanced stages of liver disease have renewed hope, thanks to findings by researchers who have discovered that a new drug significantly reduces their risk of death and need for transplantation.

26 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Cancer death rates in rural America slower to decline compared to urban areas

Study estimates number of cancer deaths in China attributable to potentially modifiable risk factors

Preserved placenta is associated with risk of infection

Health care battle on hill has veterans defending Obamacare benefits

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Vaccines can be blamed for any illness even with lack of evidence says EU court

A ‘safe’ space to shoot up: Worth a try in California?

Exclusive: White House task force echoes pharma proposals

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

UNC researchers identify how class of antiviral drugs interacts with HCV

Heroin use in the U.S. estimated to cost society more than $51 billion

Drinking few cups of coffee or tea may protect against liver fibrosis, study finds

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Grifols provides Procleix Zika Virus Assay to screen blood donations in countries that accept products with CE marking

New drug offers hope to patients with hepatitis C

FDA grants accelerated approval to cancer treatment based on common biomarker

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis C News and Research

Latest Hepatitis C News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in